|
Új bioaktív, anellált nitrogén heterociklusos vegyületek kutatása
|
súgó
nyomtatás
|
Ezen az oldalon az NKFI Elektronikus Pályázatkezelő Rendszerében nyilvánosságra hozott projektjeit tekintheti meg.
vissza »
|
|
Közleményjegyzék |
|
|
Bridges, M. D.; Hideg, K.; Hubbell, W. L.: Resolving conformational and rotameric exchange in spin labelled proteins using saturation recovery EPR, Appl. Magn. Resonance (in press), 2009 | Bordington, E.;Brutlach, H.; Urban, L.; Hideg, K.; Savitsky, A., Schnegg, A.; Gast, P.; Engelhard, M.; Groenen, E. J. J.; Möbius, K.; Steinhoff, H-J.: Heterogeneity in the nitroxide micro-environment: polarity and proticity effects in spin labelled proteins studied by multifrequency EPR., Appl, Magn. Resonance (in press), 2009 | Fleissner, M.R.; Brustad, E. M.; Kálai, T.; Altenbach, C.; Cascio, D.; Peters, F.; Hideg, K. Schultz, P. G.; Hubbell, W. L.: Site-directed Spin Labeling of a genetically Encoded Unnatural Amino Acid, P. Natl. Acad. Sci. USA (in press), 2009 | Hideg, K.; Kálai, T. Sümegi, B: Process for the preparation of 4-carboxamidobenzimidazole derivatives as PARP inhibitors and antioxidants., HU 200400883 A2 20070928, 2007 | Hideg, K.: Process for the preparation of benzo-isoselenazoles and pharmaceutical compositions containing them., HU 200105050 A2 20050428, 2005 | Hideg, E.; Kálai, T.; Kos, P.; Asada, K.; Hideg, K.: Singlet Oxygen in Plants - its Significance and Possible Detection with Double (Fluorescent and Spin) Indicator Reagents., Photochem. Photobiol. 82, 1211-1218, 2006 | Kálai, T.; Várbíró, G.; Bognár, Z.; Pálfi, A.; Hantó, K.; Bognár, B.; Ősz, E.; Sümegi, B.; Hideg, K.: Synthesis and evaluation of the permeability transition inhibitory characteristics of paramagnetic and diamagnetic amiodarone derivatives, Bioorganic & Medicinal Chemistry 13, 2629-2636., 2005 | Becker C. F. W.; Lausecker, K.; Balog, M.; Kálai, T.; Hideg, K.; Steinhoff, H-J.; Engelhard, M.: Incorporation of spin labelled amino acid into proteins, Magn. Reson. Chem. 43. S34-S39., 2005 | Pálfi, A.; Tóth, A.; Kulcsár, Gy.; Hantó, K.; Deres, P.; Bartha, É.; Halmosi, R.; Szabados, E.; Czopf, L.;Kálai, T.; Hideg, K.; Sümegi, B.;Tóth, K.: The Role of Akt and Mitogen-Activated Protein Kinase Systems in the Protective Effect Poly(ADP-Ribose) Polymerase Inhibition in Lagendorff Perfused and in Isoproterenol-D, Journal of Pharmacology and Experimental Therapeutics 315, 273-282., 2005 | Kálai, T.; Mugesh, G.; Roy, G.; Sies, H.; Berente, Z.; Hideg, K.: Combining benzol[d]isoselenazol-3-ones with sterically hindered alicyclic amines and nitroxides: enhanced activity as glutathione peroxidase mimics, Org. Biomol. Chem. 3, 3564-3569., 2005 | Kálai, T.; Jekő, J.; Berente, Z.; Hideg, K.: Palladium-Catalyzed Cross-Coupling Reactions of Paramagnetic Vinyl Bromides and Paramagnetic Boronic Acids., Synthesis 439-446, 2006 | Kovács, K.; Sümegi, B.; Tóth, A.; Deres, P.; Kálai, T.; Hideg, K.; Gallyas, F.: Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion, Biochem. Pharmacol. 71, 441-452, 2006 | Deres, P.; Halmosi, R.; Tóth, A.; Kovács, K.; Pálfi, A.; Habon, T.; Czopf, L.; Kálai, T.; Hideg, K.; Sümegi, B.; Tóth, K.: Prevention of Doxorubicin-Induced Acute Cardiotoxicity by an Experimental Antioxidant Compound, J. Cardiovasc. Pharmacol. 45(1), 36-43., 2005 | Sár, P. C.; Ősz, E.; Jekő, J.; Hideg, K.;: Synthesis of Spiro[pyrrolidine-2,2’-adamantane] Nitrones and Nirtoxides, Synthesis, 255-260, 2005 | Hideg, K.; Kálai, T.; Sár, P. C.: Recent results in chemistry and biology of nitroxides, J. Heterocyclic Chem. 42, 437-450., 2005 | Kálai, T.; Bognár, B.; Jekő, J.; Hideg, K.: Synthesis of new, paramagnetically modified heterocycles, Synthesis, 2573-2579, 2006 | Goldstein, S.; Samuni, A.; Hideg, K.; Merényi, G.: Structure-Activity Relationship of Cyclic Nitroxides as SOD Mimics and Scavengers of Nitrogen Dioxide, J. Phys. Chem. A. 110, 3679-3685., 2006 | Kutala, V. K.; Khan, M. ; Mandal, R.; Ganesan, L. P.; Tridandapani, S.; Kálai, T.; Hideg, K.; Kuppusamy, P.: Attenuation of Myocardial Ischemia-Reperfusion Injury by Trimetazidine Derivatives Functionalized with Antioxidant Properties, J. Pharm. Exp. Ther. 317, 921-928., 2006 | Cai, Q.; Kusnetzow, A. K.; Hubbell, W. L.; Haworth, I. S.; Gacho, G. P. C.; Eps, N. V.; Hideg, K.; Chambers, E. J.; Qin, P. Z.: Site-directed spin labeling measurements of nanometer distances in nucleic acids using a sequence-independent nitroxide probe, Nucl. Acid Res. 34, 4722-4730., 2006 | Kálai, T.; Khan, M.; Balog, M.; Kutala, K. V.; Kuppusamy, P.; Hideg, K.: Structure-activity studies on the protection of Trimetazidine derivatives modified with nitroxides and their precursor from myocardial ischemia-reperfusion injury, Bioorg. Med. Chem. 14, 5510-5516., 2006 | Shvetsov, A.; Stamm, J. D.; Phillips, M.; Warshaviak, D.; Altenbach, C.; Rubenstein, P. A.; Hideg, K.; Hubbell, W. L.; Reisler, E.: Conformational Dynamics of Loop 267-274 in G- and F-actin, Biochemistry 45, 6541-6549., 2006 | Lozinsky, E.; Iametti, S.; Barbiroli, A.; Likhtenshtein, G. I.; Kálai, T.; Hideg, K.; Bonomi, .F.: Structural Features of Transiently Modified Beta-Lactoglobulin Relevant to the Stable Binding of Large Hydrophobic Molecules, The Protein J. 25, 1-15., 2006 | Pálfi, A.; Tóth, A.; Hantó, K.; Deres, P.; Szabados, E.; Szereday, Z.; Kulcsár, Gy.; Kálai, T.; Hideg, K.; If. Gallyas, F.; Sümegi, B.; Tóth, K.; Halmosi, R.: PARP inhibition prevents postinfarction myocardial remodelling and heart failure via the protein kinase C/glycogen synthase kinase-3-beta pathway, J. Mol. Cell. Cardiology 41, 149-159., 2006 | Bognár, Z.; Kálai, T.; Pálfi, A.; Hantó, K.; Bognár, B.; Márk, L.; Szabó, Z.; Tapodi, A.; Radnai, B. ; Sárszegi, Zs.; Szántó, Á.; Jr. Gallyas, F.; Hideg, K.; Sümegi, B.; Várbíró, G.: A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and nectrotic cell death., Free Rad. Biol. Med. 41, 835-848., 2006 | Kálai, T.; Hideg, K.: Synthesis of New BODIPY-based Sensors and Labels, Tetrahedron 62, 10352-10360., 2006 | Raju, N.; Spacek, T.; Jezek, J.; Leinisch, F.; Hideg, K.; Jezek, P.; Trommer, W. E.: Fatty Acid Binding Site of Mitochondrial Uncoupling protein UCP2 as Probed by EPR spectroscopy of Spin-labeled Fatty Acids, Applied Magnetic Resonance, 30, 373-383, 2006 | Balog, M.; Abé, C.; Kálai, T.; Steinhoff, H. J.; Jekő, J.; Hideg, K.: Synthesis of New Paramagnetic Fatty Acids and Lipophilic Spin Labels, Synthesis. 1663-1670, 2007 | Hideg, K.; Kálai, T.: Novel Antioxidants in anthracycline cardiotoxicity, Cardiovascular Toxicol, 7, 160-164, 2007 | Cai, Q.; Kusnetzow. A. K.; Hideg, K.; Price, E. A.; Hawort, I. S.; Qin, P. Z.: Nanomewter Distance Measurements in RNA Using Site-Directed Spin Labeling, Biophysical Journal, 93, 2110-2117, 2007 | Selvendiran, K.; Tong, L.; Vishwanath, S.; Bratasz, A.;Trigg. N. J.; Kutala, V. K.; Hideg. K.; Kuppusamy, P.: EF24 Induces G2/M Arrest and Apoptosis in Cisplatin-Resistant Human Ovarian Cancer Cells by Increasing Pten Expression, J. Biol. Chem. 282, 28609-28618, 2007 | Guo, Z.; Hideg, K.; Kálai, T.; Cascio, D.; Hubbell, W. L.: Structural determinants of nitroxide motion in spin-labeled proteins: tertiary contact and solvent inaccessible sites in helix G of T4 lysozyme, Protein Science 16, 1069-1086, 2007 | Mandal, R.; Kutala, V. K.; Khan, M.; Mohan, I. K.; Varadharaj, S.; Sridhar, A.; Carnes, C. A., Hideg. K.; Kuppusamy, P.: N-hydroxy-pyrroline Modification of Verapamil Exhibits Antioxidant Protection of the Heart against Ischemia/Reperfusion-induced Cardiac Dysfunction without compromisin, J. Pharm. Exp. Ther., 323, 119-127, 2007 | Subramaniam, D.; May, R.; Sureban, S. M.; Lee, K. B.; George, R.; Kuppusamy, P.; Ramanujam, R. P.; Hideg, K.; Dieckgraefe, B. K.; Houchen, C. W.; Anant, S.: Diphenyl Difluroketone (EF24): a Curcumin Derivative with Potent In Vivo Anti-Cancer Activity, Cancer Research 68, (6), 1962-1969, 2008 | Kálai.,T.; Schindler, J.; Balog, M.; Fogassy, E.; Hideg, K.: Synthesis and resolution of new paramagnetic α-amino acids, Tetrahedron, 64, 1094-1100., 2008 | Guo, Z.; Casio, D.; Hideg, K.; Hubbell, W. L.: Structural determinants of nitroxide motion in spin-labeled proteins: Solvent-exposed sites in helix B of T4 lysozyme, Protein Science 17, 228-239, 2008 | Bognár, B. ; Kálai,T.; Hideg, K.: Synthesis of Benzimidazoles Condensed with, or Linked to, Nitroxides or Heterocyclic N-Oxides, Synthesis 2349-2445, 2008 | Mohan, I. K.; Kahn, M.; Wisel, S.; Selvendiran, K.; Sridhar, A.; Carnes, C. A.; Bognár, B.; Kálai, T.; Hideg, K.; Kuppusamy, P.: Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction, Am. J. Physiol. Heart Circ. Physiol. 296, 140-151., 2009 | Zielke, V.; Eickmeier, H.; Hideg, K.; Reuter, H.; Steinhoff, H.J.: A commonly used spin label: S-(2,2,5,5-tetramethyl-1-oxyl-Δ3-pyrrolin-3-ylmethyl) methanethiosulfonate, Crystal Structure Communications 64, 586-589., 2008 | Bartha, É.; Kiss, N. Gy.; Kálmán, E.; Kulcsár, Gy.; Kálai, T.; Hideg, K.; Habon, T.; Sümegi, B.; Tóth, K.; Halmosi, R.: Effect of L-2286, a Poly(ADP-ribose)polymerase Inhibitor and Enalapril on Myocardial Remodeling and Heart Failure, J. Cardiovacc. Pharm. 52, 253-261, 2008 | Tóth, S.; Quintavalle, D.; Náfrádi, B.; Forró, L.; Korecz, L.; Rockenbauer, A.; Kálai, T.; Hideg, K.; Simon, F.: Stability and electronic properties of magnetic peapods, Phys. Stat. Sol (b). 245, 2034-2037., 2008 | Kálai, T.; Jekő,J.; Hideg, K: Synthesis of Isoindoline Nitroxides by Elekrocyclic Reactions, Synthesis 2591-2595, 2009 | Kálai, T.; Balog, M.; Szabó, A.; Gulyás, G.; Jekő, J.; Sümegi, B.; Hideg, K.: New Poly(ADP-ribose) Polymerase-1 Inhibitors with Antioxidant Activity Based on 4-carboxamidobenzimidazol-2-yl pyrroline and -tetrahydropyridine Nitroxides and their Precursors, J. Med. Chem. 52, 1619-1629., 2009 | Kálai, T.; Hubbel, W. L.; Hideg, K.: Click Reactions with Nitroxides, Synthesis, 1336-1341, 2009 | Selvendrian, K.; Kuppusamy, M. L.; Bratasz, A.; Tong, L.; Rivera, B. K.; Rink, C.; Sen, C. K.; Kálai, T.; Hideg, K.; Kuppusamy, P.: Inhibition of vascular smooth-muscle-cell proliferation and arterial restenosis by HO-3867, a novel synthetic, J. Pharm. Exp. Ther. 329, 959-966., 2009 | Wisel, S.; Khan, M.; Kuppusamy, M. L.; Mohan, I. K.; Chacko, S. M.; Rivera, B. K.; Sun, B. C.; Hideg, K.; Kuppusamy, P.: Pharmacological preconditioning of mesenchymal stem cell with Trimetazidine protects hypoxic cells, J. Pharm. Exp. Ther. 329, 543-550., 2009 | Bartha, E.; Solti, I.; Kereskai, L.; Lantos, J.; Plozer, E.; Magyar, K.; Szabados, E.; Kalai, T. Hideg, K.; Halmosi, R.; Sumegi, B.; Toth, K.: IPARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats, Cardiovasc. Res. 83, 501-510, 2009 | Popova, A. M.; Kalai, T.; Hideg, K.; Qin, P. Z.: Site-Specific DNA Structural and Dynamic Features Revealed by Nucleotide-Independent Nitroxide Probes, Biochemistry 48, 8540-8550, 2009 |
|
|
|
|
|
|
vissza »
|
|
|